Welcome to our dedicated page for Identiv news (Ticker: INVE), a resource for investors and traders seeking the latest updates and insights on Identiv stock.
Identiv (NASDAQ: INVE) delivers innovative security solutions for physical and digital environments through RFID, IoT, and cloud-based trust services. This news hub provides investors and security technology professionals with essential updates on the company's strategic initiatives across government, healthcare, and enterprise sectors.
Access real-time updates on Identiv's product developments, financial performance, and industry partnerships. Our curated news feed covers critical announcements including quarterly earnings, new product launches, and strategic collaborations that shape the security technology landscape.
Stay informed about Identiv solutions protecting access control systems, IoT networks, and digital identity management platforms. The news collection serves as your primary source for understanding how Identiv addresses evolving cybersecurity challenges while expanding its global market presence.
Bookmark this page for streamlined access to Identiv's official communications and expert analyses. Regularly updated content ensures you maintain awareness of developments impacting both physical premises security and digital trust management ecosystems.
Identiv (NASDAQ: INVE) has announced a strategic partnership with Tag-N-Trac to develop and market IoT solutions for cold chain tracking in the pharmaceutical industry. The collaboration combines Identiv's BLE smart labels with Tag-N-Trac's RELATIVITY™ SaaS platform to provide real-time supply chain visibility and traceability.
The integrated solution enables continuous monitoring of ambient conditions like temperature and humidity for pharmaceutical products, ensuring compliance and integrity across the cold chain. Identiv's smart labels capture environmental data throughout product transit, while Tag-N-Trac's platform converts this into real-time analytics for tracking location, condition, and chain-of-custody status.
The partnership aims to address growing regulatory requirements and patient safety concerns in pharmaceutical cold chain management, particularly for temperature-sensitive products like vaccines and biologics.
Identiv (NASDAQ: INVE), a global leader in RFID and BLE-enabled IoT solutions, has scheduled its first quarter 2025 earnings conference call for Wednesday, May 7, 2025, at 5:00 PM EDT. The company will discuss financial results for Q1 ending March 31, 2025.
The earnings release will be available on the company's investor relations website before the call. Investors can join via telephone using toll-free number +1 888-506-0062 (US) or +1 973-528-0011 (International) with Call ID 500348. A webcast option is also available, and a replay will be accessible through May 21, 2025.
Identiv (NASDAQ: INVE), a global leader in RFID and BLE-enabled IoT solutions, has appointed Mick Lopez to its Board of Directors. Lopez, a public company board director and former CFO, brings decades of strategic and financial governance expertise to the company.
The new board member has extensive experience in mergers and acquisitions and corporate governance. Board Chairman James Ousley highlighted Lopez's deep financial expertise and experience in balancing growth, profitability, and capital decisions while managing complex regulatory, risk, and macroeconomic challenges.
Identiv (NASDAQ: INVE) reported its Q4 and fiscal year 2024 financial results, marking its transition into a pure play IoT solutions company. The company saw significant revenue decline with fiscal year 2024 revenue at $26.6 million compared to $43.4 million in 2023.
Key financial metrics include:
- FY2024 GAAP gross margin dropped to 1.3% from 13.8% in 2023
- Q4 2024 revenue was $6.7 million vs $11.3 million in Q4 2023
- FY2024 GAAP net loss widened to ($25.9) million, or ($1.14) per share
- Non-GAAP adjusted EBITDA loss increased to ($15.8) million in 2024
For Q1 2025, management expects revenue between $4.8-5.1 million. The company is implementing its Perform-Accelerate-Transform strategy, focusing on strengthening its team, adding strategic partnerships, and progressing with Thailand production transition.
Identiv (NASDAQ: INVE) and Novanta have announced a strategic partnership to enhance RFID solutions for healthcare OEMs. The collaboration combines Identiv's RFID inlays, tags, and labels with Novanta's ThingMagic reader modules and APIs to deliver end-to-end vertical solutions for medical device manufacturers.
The partnership will initially focus on developing RFID solutions for medical device and life science OEMs, targeting applications in smart medical devices, advanced diagnostics, and wearable devices. The integrated solutions aim to improve product performance, ensure proper assembly, and enhance patient safety.
The collaboration seeks to create an optimized ecosystem that simplifies RFID implementation for manufacturers, reducing complexity and accelerating time to market. The partnership will support connected care and medication management with real-time monitoring capabilities for patient vitals, medication compliance, and hospital asset tracking.
Identiv (NASDAQ: INVE), a global leader in RFID-enabled solutions for the Internet of Things (IoT), has announced a teleconference and webcast to discuss its financial results for the fourth quarter and fiscal year ended December 31, 2024.
The event is scheduled for Wednesday, March 5, 2025, at 5:00 PM EST. The financial results will be published in a press release prior to the call and will be available on the company's website under the investor relations section.
Details for the teleconference are as follows:
- Date: Wednesday, March 5, 2025
- Time: 5:00 PM EST (2:00 PM PST)
- Toll-Free Number: +1 888-506-0062
- International Number: +1 973-528-0011
- Call ID: 652910
The teleconference will also be webcast. To register for the live webcast or replay, please use the provided link. A replay of the teleconference will be available through March 19, 2025, by dialing +1 877-481-4010 (Toll-Free Replay Number) or +1 919-882-2331 (International Replay Number) and entering passcode 51938.
If there are any difficulties in connecting with the teleconference, contact Identiv’s investor relations team at IR@identiv.com.
Vistagen (VTGN) has initiated a repeat dose study for fasedienol, its investigational nasal spray for treating Social Anxiety Disorder (SAD). The exploratory Phase 2 trial will evaluate the efficacy, safety, and tolerability of repeat doses in adults with SAD during public speaking challenges.
The multi-center, randomized, double-blind, placebo-controlled study includes three arms: fasedienol followed by fasedienol (6.4 micrograms total), fasedienol followed by placebo (3.2 micrograms total), and placebo followed by placebo. The second dose will be administered ten minutes after the initial dose. The study design mirrors the ongoing PALISADE Phase 3 studies, including an open-label extension.
Identiv (NASDAQ: INVE) has appointed Kim Macaulay as Senior Vice President of Sales, Marketing, and Business Development. In this newly created position, Macaulay will lead the commercial organization to drive market share and execute growth initiatives, including expansion into high-value segments and driving adoption of Bluetooth Low Energy technology.
Macaulay brings nearly 40 years of experience in driving growth within Fortune 500 companies, including significant tenure at Avery Dennison where she managed over $650M in annual sales within its Retail Branding & Information Solutions Group. Prior to joining Identiv, she founded Kim Macaulay Associates, a strategy consulting firm focused on RFID, packaging, and apparel industries.
CEO Kirsten Newquist stated that Macaulay will play an integral role in implementing the company's Perform-Accelerate-Transform growth strategy.
Identiv (NASDAQ: INVE) has launched next-generation high-frequency NFC-enabled inlays featuring NXP's ICODE® 3 chip. The new ID-Tune I3 and ID-Safe I3 NFC tags offer enhanced RF performance, faster reading speeds up to 212kbit/s, and improved data security features.
The inlays include advanced features like SELFAdjust technology for optimal readability across materials, customizable originality signatures, and password-protected modes. These solutions target various sectors including healthcare, libraries, logistics, smart packaging, and specialty retail, supporting applications from product tracking to brand protection.
Identiv (NASDAQ: INVE), a global leader in RFID-enabled IoT solutions, announced a $10 million stock repurchase program. This reflects the Board's confidence in the company's new growth strategy and belief that shares are undervalued. The program is open-ended and will be funded from existing cash or future cash flow. As of September 30, 2024, Identiv had over $145 million in cash and equivalents and 23,873,249 shares outstanding.
The Board also plans to propose corporate governance enhancements before the 2025 annual meeting. These include eliminating the classified Board structure, requiring directors who don't receive majority votes to consider resignation, and eliminating option repricing in the stock incentive plan. The Board is recruiting new directors with complementary expertise to guide the company's transition.
